BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16917833)

  • 1. Application of preferential crystallization to resolve racemic compounds in a hybrid process.
    Lorenz H; Polenske D; Seidel-Morgenstern A
    Chirality; 2006 Nov; 18(10):828-40. PubMed ID: 16917833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hybrid process for chiral separation of compound-forming systems.
    Gou L; Robl S; Leonhard K; Lorenz H; Sordo M; Butka A; Kesselheim S; Wolff M; Seidel-Morgenstern A; Schaber K
    Chirality; 2011 Feb; 23(2):118-27. PubMed ID: 20845428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of different techniques of preferential crystallization for enantioseparation of racemic compound forming systems.
    Polenske D; Lorenz H; Seidel-Morgenstern A
    Chirality; 2009 Aug; 21(8):728-37. PubMed ID: 18989897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Online monitoring of preferential crystallization of enantiomers.
    Alvarez Rodrigo A; Lorenz H; Seidel-Morgenstern A
    Chirality; 2004 Oct; 16(8):499-508. PubMed ID: 15290684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isolation of a metastable conglomerate using a combined computational and controlled crystallization approach.
    Davey RJ; Sadiq G; Back K; Wilkinson L; Seaton CC
    Chem Commun (Camb); 2012 Feb; 48(14):1976-8. PubMed ID: 22117223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study and simplified mathematical description of preferential crystallization.
    Elsner MP; Fernández Menéndez D; Muslera EA; Seidel-Morgenstern A
    Chirality; 2005; 17 Suppl():S183-95. PubMed ID: 15856522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomer resolution by pressure increase: inferences from experimental and topological results for the binary enantiomer system (R)- and (S)-mandelic acid.
    Rietveld IB; Barrio M; Tamarit JL; Do B; Céolin R
    J Phys Chem B; 2011 Dec; 115(49):14698-703. PubMed ID: 22047025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
    Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
    J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the Crystal Structures of Enantiopure and Racemic Mandelic Acids Determined by Kinetics or Thermodynamics?
    Hylton RK; Tizzard GJ; Threlfall TL; Ellis AL; Coles SJ; Seaton CC; Schulze E; Lorenz H; Seidel-Morgenstern A; Stein M; Price SL
    J Am Chem Soc; 2015 Sep; 137(34):11095-104. PubMed ID: 26244445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
    Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
    J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-assisted physicochemical enantioseparation processes-Part III: Overcoming yield limitations by dynamic kinetic resolution of asparagine via preferential crystallization and enzymatic racemization.
    Würges K; Petrusevska-Seebach K; Elsner MP; Lütz S
    Biotechnol Bioeng; 2009 Dec; 104(6):1235-9. PubMed ID: 19655380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation.
    Choobdari E; Fakhraian H; Peyrovi MH
    Chirality; 2014 Mar; 26(3):183-8. PubMed ID: 24574075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral crystallization of glutamic acid on self assembled films of cysteine.
    Dressler DH; Mastai Y
    Chirality; 2007 May; 19(5):358-65. PubMed ID: 17354265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The separation of racemic crystals into enantiomers by chiral block copolymers.
    Mastai Y; Sedlák M; Cölfen H; Antonietti M
    Chemistry; 2002 Jun; 8(11):2429-37. PubMed ID: 12180321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Chiral Resolution of Two Racemic Compounds by Preferential Cocrystallization*.
    Zhou F; Shemchuk O; Charpentier MD; Matheys C; Collard L; Ter Horst JH; Leyssens T
    Angew Chem Int Ed Engl; 2021 Sep; 60(37):20264-20268. PubMed ID: 34233036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chiral self assembled monolayers as resolving auxiliaries in the crystallization of valine.
    Singh A; Myerson AS
    J Pharm Sci; 2010 Sep; 99(9):3931-40. PubMed ID: 20533552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of Halogenated Mandelic Acids through Enantiospecific Co-Crystallization with Levetiracetam.
    Wang J; Peng Y
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct enantiomeric TLC resolution of dl-penicillamine using (R)-mandelic acid and l-tartaric acid as chiral impregnating reagents and as chiral mobile phase additive.
    Bhushan R; Agarwal C
    Biomed Chromatogr; 2008 Nov; 22(11):1237-42. PubMed ID: 18651593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
    Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
    Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.